Clinical Trial

NIR Fluorescence Imaging of Lymphatic Transport Using ICG

Study Description

NIR Fluorescence Imaging of Lymphatic Transport Using ICG

In this phase 1 study, the lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities in healthy individuals using a MultiSpectral Imaging System (MSImager).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Indocyanine Green

A trained physician will inject 0.1 ml of Indocyanine Green into the web spaces of the hands in both upper extremities. Subjects may have up to five study visits to confirm feasibility, safety, and reproducibility.

Device - MultiSpectral Imaging System

Once the Indocyanine Green is injected, the contrast is expected to fluoresce underneath the MultiSpectral Imaging System. Multispectral video and still images will be recorded at the study visits.

Additional Information

Official Study Title

Near InfraRed Fluorescence Imaging of Lymphatic Transport Using Indocyanine Green

Clinical Trial ID

NCT02680067

ParticipAid ID

negMjb